[
  {
    "ts": "2025-10-10T20:15:00+00:00",
    "headline": "Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs",
    "summary": "PARSIPPANY, N.J., October 10, 2025--If approved, Lenivia will be a new antibody therapy that reduces OA pain in dogs for three months with one injection.",
    "url": "https://finance.yahoo.com/news/zoetis-receives-positive-opinion-cvmp-201500984.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "961a6487-a33f-3129-b5b1-feed80c8a3ba",
      "content": {
        "id": "961a6487-a33f-3129-b5b1-feed80c8a3ba",
        "contentType": "STORY",
        "title": "Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs",
        "description": "",
        "summary": "PARSIPPANY, N.J., October 10, 2025--If approved, Lenivia will be a new antibody therapy that reduces OA pain in dogs for three months with one injection.",
        "pubDate": "2025-10-10T20:15:00Z",
        "displayTime": "2025-10-10T20:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/dc1799d14a28c552bc8ce9d559321123",
          "originalWidth": 1035,
          "originalHeight": 387,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MDOppFeufHioJiogz7TSdA--~B/aD0zODc7dz0xMDM1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/dc1799d14a28c552bc8ce9d559321123.cf.webp",
              "width": 1035,
              "height": 387,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Fm0Wzi81S5h5ey5sNnybEw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/dc1799d14a28c552bc8ce9d559321123.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-receives-positive-opinion-cvmp-201500984.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-receives-positive-opinion-cvmp-201500984.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-10T20:05:12+00:00",
    "headline": "Zoetis (ZTS): Assessing Valuation Following Dividend Announcement and FDA Nod for Dectomax-CA1 Injectable",
    "summary": "Zoetis, the world’s largest animal health company, has grabbed attention after its Board declared a fourth-quarter dividend of $0.50 per share. This move continues the firm’s long-standing streak of rewarding shareholders. See our latest analysis for Zoetis. Zoetis has seen a challenging stretch, with a 1-year total shareholder return of -23.7% and the latest share price closing at $143.39. Even as momentum has faded in recent months, the recent FDA approval for its Dectomax-CA1 Injectable...",
    "url": "https://finance.yahoo.com/news/zoetis-zts-assessing-valuation-following-200512908.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f20d72d3-df71-3989-9cdc-a138c30a633e",
      "content": {
        "id": "f20d72d3-df71-3989-9cdc-a138c30a633e",
        "contentType": "STORY",
        "title": "Zoetis (ZTS): Assessing Valuation Following Dividend Announcement and FDA Nod for Dectomax-CA1 Injectable",
        "description": "",
        "summary": "Zoetis, the world’s largest animal health company, has grabbed attention after its Board declared a fourth-quarter dividend of $0.50 per share. This move continues the firm’s long-standing streak of rewarding shareholders. See our latest analysis for Zoetis. Zoetis has seen a challenging stretch, with a 1-year total shareholder return of -23.7% and the latest share price closing at $143.39. Even as momentum has faded in recent months, the recent FDA approval for its Dectomax-CA1 Injectable...",
        "pubDate": "2025-10-10T20:05:12Z",
        "displayTime": "2025-10-10T20:05:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/3a10ea4e2d99097fafd252f90cc495f0",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/f0C7t6iQjaUXO6Sb_gR7gg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3a10ea4e2d99097fafd252f90cc495f0.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xjacLb9JseQC0Y25VVBzKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/3a10ea4e2d99097fafd252f90cc495f0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-zts-assessing-valuation-following-200512908.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-zts-assessing-valuation-following-200512908.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]